Post job

Relay Therapeutics executives

Here are further demographic highlights of the leadership team:
  • The Relay Therapeutics executive team is 33% female and 67% male.
  • 64% of the management team is White.
  • 9% of Relay Therapeutics management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Relay Therapeutics?
Share your experience

Rate Relay Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Mark Murcko

Founder

David E. Shaw

Chief Scientist

Matthew Jacobson

Board Member

Dorothee Kern

Founder

Ben B. Wolf

Chief Medical Officer

Ben B. Wolf's LinkedIn

Ben B. Wolf is a precision oncologist who brings to Relay nearly 20 years of experience in the biopharmaceutical industry, with expertise advancing new oncology programs in the clinic and optimizing patient selection to enable rapid proof of concept and registration. He has authored more than 30 peer-reviewed publications and multiple patents related to drug discoveries.

Most recently, Ben served as chief medical officer at KSQ Therapeutics, a biotechnology company advancing a pipeline of CRISPR-based tumor- and immune-focused drug candidates for the treatment of cancer. Prior to KSQ, he was senior vice president, clinical development at Blueprint Medicines, where he advanced three oncology programs for novel kinase inhibitors from investigational new drug (IND) applications to clinical proof-of-concept. Prior to Blueprint, Ben held clinical and medical director roles at Merrimack Pharmaceuticals, ImmunoGen, Amgen and Genentech.

Ben holds an M.D. and Ph.D. in biochemistry from the University of Virginia and a B.S. from Union College. He completed medical training in internal medicine and medical oncology at the University of California at San Diego.

Sanjiv K. Patel

Board Member

Sanjiv K. Patel's LinkedIn

Alexis Borisy

Board Member

Andy Porter

Chief People Experience Officer

Andy Porter's LinkedIn

Prior to Relay, Andy Porter served for more than five years as the chief people officer at the Broad Institute of MIT and Harvard, where he was responsible for leading the human resources strategy for a community of 4,000 people, as well as leading space planning and design for Broad’s campus in Cambridge. Before that, he was vice president of human resources and organizational development at Merrimack Pharmaceuticals, held roles at Dyax Corp. and held roles in human resources at Harvard-affiliated hospitals.

Andy is a member of the board of directors for the Northeast Human Resources Association and is a frequent speaker at industry conferences. He has also spent time outside of his full-time roles teaching as an adjunct professor at Massachusetts College of Pharmacy and Health Science.

Andy holds a B.S. in organizational psychology from Bridgewater State University and an M.S. in organization development from American University.

Kanishka Pothula

Board Member

Brian Adams

General Counsel

Do you work at Relay Therapeutics?

Does leadership effectively guide Relay Therapeutics toward its goals?

Relay Therapeutics jobs

Relay Therapeutics founders

Name & TitleBio
Mark Murcko

Founder

David E. Shaw

Chief Scientist

Matthew Jacobson

Board Member

Dorothee Kern

Founder

Relay Therapeutics board members

Name & TitleBio
Mark Murcko

Founder

Matthew Jacobson

Board Member

Sanjiv K. Patel

Board Member

Sanjiv K. Patel's LinkedIn

Alexis Borisy

Board Member

Kanishka Pothula

Board Member

Dr Linda Hill

Board Member

Jami Rubin

Board Member

Krishna Yeshwant

Board Member

Laura Shawver

Board Member

Steve Kafka

Board Member

Relay Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Relay Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Relay Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Relay Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Relay Therapeutics. The data presented on this page does not represent the view of Relay Therapeutics and its employees or that of Zippia.

Relay Therapeutics may also be known as or be related to RELAY THERAPEUTICS, INC., Relay Therapeutics and Relay Therapeutics, Inc.